Work

Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients

Year: 2019

Type: article

Study design: Clinical Trial

Source: International Journal of Gynecological Cancer

DOI: 10.1136/ijgc-2018-000035

Authors: Saul Eugene Rivkin, James Moon, Desiree S Iriarte, Erik Bailey, Heather L Sloan, Gary E Goodman, Amy E BonDurant, Dan Velijovich, Tanya Wahl, Peter Jiang, Chirag A Shah, Charles Drescher, Mehmet F Fer, Henry G Kaplan, Erin D Ellis

Institutions: Rivkin Center for Ovarian Cancer, Fred Hutch Cancer Center, Providence Regional Cancer Partnership

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2913589471

FWCI: 1.348

Cites: 44

Cited by: 17

Related to: 10